CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Ambrx Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Ambrx Inc
10975 North Torrey Pines Road
Phone: (858) 875-2400p:858 875-2400 LA JOLLA, CA  92037  United States Fax: (858) 453-9511f:858 453-9511

Business Summary
Ambrx, Inc. is a United States-based biopharmaceutical company. The Company delivers protein therapeutics using an expanded genetic code to create precision biologics, this includes antibody drug conjugates (ADCs), bispecifics, and targeted immuno-oncology therapies for cancer as well as cytokines to modulate the immune system and therapeutic peptides for metabolic and cardiovascular disease, designed to have improved pharmacologic properties and novel biological activity. The Company's technology platforms combine the conventional medicinal chemistry with cutting edge recombinant DNA-based protein biosynthesis. It also combines site-specific conjugation with linkers, payloads and pharmacokinetic extenders to create a single molecular species.

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-YesYesYes---

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
3/31/201412/31/2013YesYes---

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board KatrinRupalla 55 11/1/2022 11/1/2022
Chief Executive Officer, Director, President Daniel E.O'connor
Chief Financial Officer SonjaNelson 11/1/2022 6/1/2021
Chief Technology Officer YingBuechler 10/1/2022 10/1/2022
Chief Scientific Officer ShawnZhang 11/1/2022

General Information
Number of Employees: 74 (As of 3/31/2014)
Outstanding Shares: 17,171,371 (As of 6/9/2014)
Stock Exchange: NASD
Federal Tax Id: 571147346
Fax Number: (858) 453-9511
Email Address: info@ambrx.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Monday, August 28, 2023